Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

An Easy and Reliable Strategy for Making Type I Interferon Signature Analysis Comparable among Research Centers.

Pin A, Monasta L, Taddio A, Piscianz E, Tommasini A, Tesser A.

Diagnostics (Basel). 2019 Sep 4;9(3). pii: E113. doi: 10.3390/diagnostics9030113.

2.

Familial hypogammaglobulinemia with high RTE and naïve T lymphocytes.

Piscianz E, Conversano E, Bianco AM, Faletra F, Tommasini A, Valencic E.

Inflamm Res. 2019 Aug 29. doi: 10.1007/s00011-019-01277-1. [Epub ahead of print]

PMID:
31468084
3.

Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network.

Cirillo E, Cancrini C, Azzari C, Martino S, Martire B, Pession A, Tommasini A, Naviglio S, Finocchi A, Consolini R, Pierani P, D'Alba I, Putti MC, Marzollo A, Giardino G, Prencipe R, Esposito F, Grasso F, Scarselli A, Di Matteo G, Attardi E, Ricci S, Montin D, Specchia F, Barzaghi F, Cicalese MP, Quaremba G, Lougaris V, Giliani S, Locatelli F, Rossi P, Aiuti A, Badolato R, Plebani A, Pignata C.

Front Immunol. 2019 Aug 13;10:1908. doi: 10.3389/fimmu.2019.01908. eCollection 2019.

4.

Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature.

Trombetta A, Ghirardo S, Pastore S, Tesser A, Piscianz E, Tommasini A, Bobbo M, Taddio A.

Pulm Circ. 2019 Aug 9;9(3):2045894019869837. doi: 10.1177/2045894019869837. eCollection 2019 Jul-Sep.

5.

Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency.

Valencic E, Piscianz E, Sirchia F, Tommasini A, Faletra F, Todaro F, Spinelli AM, Badolato R.

Immunol Lett. 2019 Oct;214:52-54. doi: 10.1016/j.imlet.2019.08.003. Epub 2019 Aug 20. No abstract available.

PMID:
31442541
6.

Diagnostic Approach to Monogenic Inflammatory Bowel Disease in Clinical Practice: A Ten-Year Multicentric Experience.

Lega S, Pin A, Arrigo S, Cifaldi C, Girardelli M, Bianco AM, Malamisura M, Angelino G, Faraci S, Rea F, Romeo EF, Aloi M, Romano C, Barabino A, Martelossi S, Tommasini A, Di Matteo G, Cancrini C, De Angelis P, Finocchi A, Bramuzzo M.

Inflamm Bowel Dis. 2019 Aug 3. pii: izz178. doi: 10.1093/ibd/izz178. [Epub ahead of print]

PMID:
31375816
7.

Combined Analysis of Methylation and Gene Expression Profiles in Separate Compartments of Small Bowel Mucosa Identified Celiac Disease Patients' Signatures.

Cielo D, Galatola M, Fernandez-Jimenez N, De Leo L, Garcia-Etxebarria K, Loganes C, Tommasini A, Not T, Auricchio R, Greco L, Bilbao JR.

Sci Rep. 2019 Jul 10;9(1):10020. doi: 10.1038/s41598-019-46468-2.

8.

Off-Label Use of Sirolimus and Everolimus in a Pediatric Center: A Case Series and Review of the Literature.

Bevacqua M, Baldo F, Pastore S, Valencic E, Tommasini A, Maestro A, Rabusin M, Arbo A, Barbi E.

Paediatr Drugs. 2019 Jun;21(3):185-193. doi: 10.1007/s40272-019-00337-7.

PMID:
31124053
9.

B-cell depletion induces prolonged remission in patients with giant cell hepatitis and autoimmune hemolytic anemia.

Matarazzo L, Di Chio T, Nastasio S, Tommasini A, Ventura A, Maggiore G.

Clin Res Hepatol Gastroenterol. 2019 May 7. pii: S2210-7401(19)30087-7. doi: 10.1016/j.clinre.2019.03.010. [Epub ahead of print]

PMID:
31076361
10.

Hughes Stovin: Sustained remission and regression of pulmonary aneurysms with anti-tumor necrosis factor treatment.

Ghirardo S, Pastore S, Gortani G, Tommasini A, Taddio A.

Pediatr Pulmonol. 2019 Jun;54(6):E13-E15. doi: 10.1002/ppul.24298. Epub 2019 Apr 2.

PMID:
30938918
11.

A Case of Uveitis in a Patient With Juvenile Myelomonocytic Leukemia Successfully Treated With Adalimumab.

Cortellazzo Wiel L, Pastore S, Taddio A, Tommasini A.

J Pediatr Hematol Oncol. 2019 Feb 22. doi: 10.1097/MPH.0000000000001448. [Epub ahead of print]

PMID:
30807392
12.

Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients.

Maximova N, Granzotto M, Barbieri F, Marcuzzi A, Tommasini A, Monasta L, Simeone R, Zanon D, Sala R.

Cancer Med. 2019 Mar;8(3):890-901. doi: 10.1002/cam4.1912. Epub 2019 Jan 28.

13.

Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism?

Piscianz E, Vecchi Brumatti L, Tommasini A, Marcuzzi A.

Neural Regen Res. 2019 Apr;14(4):582-587. doi: 10.4103/1673-5374.247441. Review.

14.

The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases.

Bernardi S, Marcuzzi A, Piscianz E, Tommasini A, Fabris B.

Int J Mol Sci. 2018 Dec 14;19(12). pii: E4058. doi: 10.3390/ijms19124058. Review.

15.

Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children.

Mazzoni E, Frontini F, Rotondo JC, Zanotta N, Fioravanti A, Minelli F, Torreggiani E, Campisciano G, Marcuzzi A, Guerra G, Tommasini A, Touzé A, Martini F, Tognon M, Comar M.

J Cell Physiol. 2019 Apr;234(4):3170-3179. doi: 10.1002/jcp.27490. Epub 2018 Oct 26.

PMID:
30362540
16.

Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering.

Tommasini A, Magnolato A, Bruno I.

World J Clin Pediatr. 2018 Aug 30;7(3):75-82. doi: 10.5409/wjcp.v7.i3.75. eCollection 2018 Aug 30.

17.

Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis.

Ferrara G, Pastore S, Sancin L, Torelli L, Radillo O, Bramuzzo M, Bibalo C, Tommasini A, Ventura A, Taddio A.

J Rheumatol. 2018 Oct;45(10):1418-1421. doi: 10.3899/jrheum.171200. Epub 2018 Jun 15.

PMID:
29907671
18.

Neuronal Dysfunction Associated with Cholesterol Deregulation.

Marcuzzi A, Loganes C, Valencic E, Piscianz E, Monasta L, Bilel S, Bortul R, Celeghini C, Zweyer M, Tommasini A.

Int J Mol Sci. 2018 May 19;19(5). pii: E1523. doi: 10.3390/ijms19051523.

19.

Novel NOD2 Mutation in Early-Onset Inflammatory Bowel Phenotype.

Girardelli M, Loganes C, Pin A, Stacul E, Decleva E, Vozzi D, Baj G, De Giacomo C, Tommasini A, Bianco AM.

Inflamm Bowel Dis. 2018 May 18;24(6):1204-1212. doi: 10.1093/ibd/izy061.

PMID:
29697845
20.

Long term outcome of eight patients with type 1 Leukocyte Adhesion Deficiency (LAD-1): Not only infections, but high risk of autoimmune complications.

De Rose DU, Giliani S, Notarangelo LD, Lougaris V, Lanfranchi A, Moratto D, Martire B, Specchia F, Tommasini A, Plebani A, Badolato R.

Clin Immunol. 2018 Jun;191:75-80. doi: 10.1016/j.clim.2018.03.005. Epub 2018 Mar 13.

PMID:
29548898
21.

Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency.

Valencic E, Grasso AG, Conversano E, Lucafò M, Piscianz E, Gregori M, Conti F, Cancrini C, Tommasini A.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2165-2167. doi: 10.1016/j.jaip.2018.02.029. Epub 2018 Mar 3. No abstract available.

PMID:
29510232
22.

Low-dose sirolimus in two cousins with autoimmune lymphoproliferative syndrome-associated infection.

Nocerino A, Valencic E, Loganes C, Pelos G, Tommasini A.

Pediatr Int. 2018 Mar;60(3):315-317. doi: 10.1111/ped.13494. Epub 2018 Feb 26. No abstract available.

PMID:
29480551
23.

Neither hereditary periodic fever nor periodic fever, aphthae, pharingitis, adenitis: Undifferentiated periodic fever in a tertiary pediatric center.

De Pauli S, Lega S, Pastore S, Grasso DL, Bianco AMR, Severini GM, Tommasini A, Taddio A.

World J Clin Pediatr. 2018 Feb 8;7(1):49-55. doi: 10.5409/wjcp.v7.i1.49. eCollection 2018 Feb 8.

24.

Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach.

Taddio A, Ferrara G, Insalaco A, Pardeo M, Gregori M, Finetti M, Pastore S, Tommasini A, Ventura A, Gattorno M.

Pediatr Rheumatol Online J. 2017 Dec 29;15(1):87. doi: 10.1186/s12969-017-0216-7. Review.

25.

Type I interferon-mediated autoinflammation due to DNase II deficiency.

Rodero MP, Tesser A, Bartok E, Rice GI, Della Mina E, Depp M, Beitz B, Bondet V, Cagnard N, Duffy D, Dussiot M, Frémond ML, Gattorno M, Guillem F, Kitabayashi N, Porcheray F, Rieux-Laucat F, Seabra L, Uggenti C, Volpi S, Zeef LAH, Alyanakian MA, Beltrand J, Bianco AM, Boddaert N, Brouzes C, Candon S, Caorsi R, Charbit M, Fabre M, Faletra F, Girard M, Harroche A, Hartmann E, Lasne D, Marcuzzi A, Neven B, Nitschke P, Pascreau T, Pastore S, Picard C, Picco P, Piscianz E, Polak M, Quartier P, Rabant M, Stocco G, Taddio A, Uettwiller F, Valencic E, Vozzi D, Hartmann G, Barchet W, Hermine O, Bader-Meunier B, Tommasini A, Crow YJ.

Nat Commun. 2017 Dec 19;8(1):2176. doi: 10.1038/s41467-017-01932-3.

26.

Genetic profile of patients with early onset inflammatory bowel disease.

Girardelli M, Basaldella F, Paolera SD, Vuch J, Tommasini A, Martelossi S, Crovella S, Bianco AM.

Gene. 2018 Mar 1;645:18-29. doi: 10.1016/j.gene.2017.12.029. Epub 2017 Dec 15.

PMID:
29248579
27.

The Challenge of Next Generation Sequencing in a Boy With Severe Mononucleosis and EBV-related Lymphoma.

Verzegnassi F, Valencic E, Kiren V, Giurici N, Bianco AM, Marcuzzi A, Vozzi D, Tommasini A, Faletra F.

J Pediatr Hematol Oncol. 2018 Jul;40(5):e323-e326. doi: 10.1097/MPH.0000000000001004.

PMID:
29176466
28.

Cryopyrin-associated Periodic Syndromes in Italian Patients: Evaluation of the Rate of Somatic NLRP3 Mosaicism and Phenotypic Characterization.

Lasigliè D, Mensa-Vilaro A, Ferrera D, Caorsi R, Penco F, Santamaria G, Di Duca M, Amico G, Nakagawa K, Antonini F, Tommasini A, Consolini R, Insalaco A, Cattalini M, Obici L, Gallizzi R, Santarelli F, Del Zotto G, Severino M, Rubartelli A, Ravazzolo R, Martini A, Ceccherini I, Nishikomori R, Gattorno M, Arostegui JI, Borghini S.

J Rheumatol. 2017 Nov;44(11):1667-1673. doi: 10.3899/jrheum.170041. Epub 2017 Sep 15.

PMID:
28916543
29.

Reappraisal of Antimalarials in Interferonopathies: New Perspectives for Old Drugs.

Piscianz E, Cuzzoni E, Sharma R, Tesser A, Sapra P, Tommasini A.

Curr Med Chem. 2018;25(24):2797-2810. doi: 10.2174/0929867324666170911162331. Review.

PMID:
28901270
30.

Repositioning Drugs for Rare Immune Diseases: Hopes and Challenges for a Precision Medicine.

Valencic E, Smid A, Jakopin Z, Tommasini A, Mlinaric-Rascan I.

Curr Med Chem. 2018;25(24):2764-2782. doi: 10.2174/0929867324666170830101215. Review.

PMID:
28875839
31.

Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease.

Lucafò M, Di Silvestre A, Romano M, Avian A, Antonelli R, Martelossi S, Naviglio S, Tommasini A, Stocco G, Ventura A, Decorti G, De Iudicibus S.

Basic Clin Pharmacol Toxicol. 2018 Jan;122(1):87-93. doi: 10.1111/bcpt.12851. Epub 2017 Aug 9.

32.

Curcumin Anti-Apoptotic Action in a Model of Intestinal Epithelial Inflammatory Damage.

Loganes C, Lega S, Bramuzzo M, Vecchi Brumatti L, Piscianz E, Valencic E, Tommasini A, Marcuzzi A.

Nutrients. 2017 Jun 6;9(6). pii: E578. doi: 10.3390/nu9060578.

33.

ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.

Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, Conti G, Marchetti F, Picco P, Tommasini A, Martino S, Malattia C, Gallizi R, Podda RA, Salis A, Falcini F, Schena F, Garbarino F, Morreale A, Pardeo M, Ventrici C, Passarelli C, Zhou Q, Severino M, Gandolfo C, Damonte G, Martini A, Ravelli A, Aksentijevich I, Ceccherini I, Gattorno M.

Ann Rheum Dis. 2017 Oct;76(10):1648-1656. doi: 10.1136/annrheumdis-2016-210802. Epub 2017 May 18. Erratum in: Ann Rheum Dis. 2019 Jul;78(7):e73.

PMID:
28522451
34.

Cervical-length measurement in mid-gestation to predict spontaneous preterm birth in asymptomatic triplet pregnancy.

Fichera A, Pagani G, Stagnati V, Cascella S, Faiola S, Gaini C, Lanna M, Pasquini L, Raffaelli R, Stampalija T, Tommasini A, Prefumo F.

Ultrasound Obstet Gynecol. 2018 May;51(5):614-620. doi: 10.1002/uog.17464. Epub 2018 Apr 10.

35.

Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease.

Loganes C, Valencic E, Pin A, Marini E, Martelossi S, Naviglio S, De Leo L, Not T, Monasta L, Tommasini A, Marcuzzi A.

World J Gastroenterol. 2016 Nov 28;22(44):9734-9743.

36.

Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.

Loganes C, Pin A, Naviglio S, Girardelli M, Bianco AM, Martelossi S, Tommasini A, Piscianz E.

World J Gastroenterol. 2016 Nov 7;22(41):9117-9126.

37.

Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis.

Anderson BJ, Reilly JP, Shashaty MGS, Palakshappa JA, Wysoczanski A, Dunn TG, Kazi A, Tommasini A, Mikkelsen ME, Schweickert WD, Kolson DL, Christie JD, Meyer NJ.

J Crit Care. 2016 Dec;36:18-23. doi: 10.1016/j.jcrc.2016.06.012. Epub 2016 Jun 23.

38.

Neutropenic sepsis is associated with distinct clinical and biological characteristics: a cohort study of severe sepsis.

Reilly JP, Anderson BJ, Hudock KM, Dunn TG, Kazi A, Tommasini A, Charles D, Shashaty MG, Mikkelsen ME, Christie JD, Meyer NJ.

Crit Care. 2016 Jul 18;20(1):222. doi: 10.1186/s13054-016-1398-y.

39.

Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis.

Abate MV, Stocco G, Devescovi R, Carrozzi M, Pierobon C, Valencic E, Lucafò M, Di Silvestre A, D'Adamo P, Tommasini A, Decorti G, Ventura A.

Blood Cells Mol Dis. 2016 Jul;59:97-9. doi: 10.1016/j.bcmd.2016.05.001. Epub 2016 May 3. No abstract available.

PMID:
27282575
40.

Describing Kawasaki shock syndrome: results from a retrospective study and literature review.

Taddio A, Rossi ED, Monasta L, Pastore S, Tommasini A, Lepore L, Bronzetti G, Marrani E, Mottolese BD, Simonini G, Cimaz R, Ventura A.

Clin Rheumatol. 2017 Jan;36(1):223-228. doi: 10.1007/s10067-016-3316-8. Epub 2016 May 26. Review.

PMID:
27230223
41.

Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes.

Piscianz E, Candilera V, Valencic E, Loganes C, Paron G, De Iudicibus S, Decorti G, Tommasini A.

Mol Med Rep. 2016 Jul;14(1):574-82. doi: 10.3892/mmr.2016.5263. Epub 2016 May 13.

PMID:
27175898
42.

Clinical Characteristics of Patients Carrying the Q703K Variant of the NLRP3 Gene: A 10-year Multicentric National Study.

Naselli A, Penco F, Cantarini L, Insalaco A, Alessio M, Tommasini A, Maggio C, Obici L, Gallizi R, Cimmino M, Signa S, Lucherini OM, Carta S, Caroli F, Martini A, Rubartelli A, Ceccherini I, Gattorno M.

J Rheumatol. 2016 Jun;43(6):1093-100. doi: 10.3899/jrheum.150962. Epub 2016 Apr 1.

PMID:
27036377
43.

Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance.

Lucafò M, Bravin V, Tommasini A, Martelossi S, Rabach I, Ventura A, Decorti G, De Iudicibus S.

Clin Exp Pharmacol Physiol. 2016 Jun;43(6):602-5. doi: 10.1111/1440-1681.12572.

PMID:
27001230
44.

Low Plasma Levels of Adiponectin Do Not Explain Acute Respiratory Distress Syndrome Risk: a Prospective Cohort Study of Patients with Severe Sepsis.

Palakshappa JA, Anderson BJ, Reilly JP, Shashaty MG, Ueno R, Wu Q, Ittner CA, Tommasini A, Dunn TG, Charles D, Kazi A, Christie JD, Meyer NJ.

Crit Care. 2016 Mar 16;20:71. doi: 10.1186/s13054-016-1244-2.

45.

Putative modifier genes in mevalonate kinase deficiency.

Marcuzzi A, Vozzi D, Girardelli M, Tricarico PM, Knowles A, Crovella S, Vuch J, Tommasini A, Piscianz E, Bianco AM.

Mol Med Rep. 2016 Apr;13(4):3181-9. doi: 10.3892/mmr.2016.4918. Epub 2016 Feb 22.

PMID:
26935981
46.

Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway.

Marcuzzi A, Piscianz E, Loganes C, Vecchi Brumatti L, Knowles A, Bilel S, Tommasini A, Bortul R, Zweyer M.

Int J Mol Sci. 2015 Dec 30;17(1). pii: E47. doi: 10.3390/ijms17010047. Review.

47.

The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency.

Girardelli M, Arrigo S, Barabino A, Loganes C, Morreale G, Crovella S, Tommasini A, Bianco AM.

BMC Pediatr. 2015 Dec 15;15:208. doi: 10.1186/s12887-015-0522-5.

48.

Genetics of inflammatory bowel disease from multifactorial to monogenic forms.

Bianco AM, Girardelli M, Tommasini A.

World J Gastroenterol. 2015 Nov 21;21(43):12296-310. doi: 10.3748/wjg.v21.i43.12296. Review.

49.

Fever tree revisited: From malaria to autoinflammatory diseases.

Pastore S, Vuch J, Bianco AM, Taddio A, Tommasini A.

World J Clin Pediatr. 2015 Nov 8;4(4):106-12. doi: 10.5409/wjcp.v4.i4.106. eCollection 2015 Nov 8. Review.

50.

Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?

Stocco G, Lanzi G, Yue F, Giliani S, Sasaki K, Tommasini A, Pelin M, Martelossi S, Ventura A, Decorti G.

Curr Drug Metab. 2015;17(1):91-8. Review.

PMID:
26526832

Supplemental Content

Loading ...
Support Center